GLENMARK:NSE
Glenmark Pharmaceuticals Ltd
₹2,283.00
arrow_downward
-0.44%(-10.00) 1D
Oct 12, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLENMARK...
Open
₹2,275.00
High
₹2,293.90
Low
₹2,252.00
Mkt. cap
644.32B
Avg. vol.
586.00K
Volume
695.53K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
35.85
52-wk high
₹2,537.60
52-wk low
₹1,792.60
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
Open
₹2,275.00
High
₹2,293.90
Low
₹2,252.00
Mkt. cap
644.32B
Avg. vol.
586.00K
Volume
695.53K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
35.85
52-wk high
₹2,537.60
52-wk low
₹1,792.60
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
News stories
From web sources and news partners
bloomingbit
·
24 minutes ago
U.S. Stocks Turn Mixed; Nasdaq Falls 0.20%
TradingView
·
17 minutes ago
S&P 500 surpasses 1,000 trading days without a new 52-week low
IndexBox
·
16 minutes ago
S&P 500 Record High Masks US Household Financial Strain
TradeWinds News
·
3 days ago
Nordic American Tankers top stock as shipping crushes S&P 500 in unprecedented quarter
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd
CEO-
Employees16.9K
FoundedNov 18, 1977
Headquarters-
SectorPharmaceutical industry
Websiteglenmarkpharma.com